Common Stock, Shares Authorized of Kiniksa Pharmaceuticals International, plc from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Kiniksa Pharmaceuticals International, plc quarterly Common Stock, Shares Authorized in shares history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Kiniksa Pharmaceuticals International, plc Common Stock, Shares Authorized for the quarter ending 31 Dec 2025 was 200,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Kiniksa Pharmaceuticals International, plc Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 200,000,000 0 0% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q4 2024 200,000,000 0 0% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q4 2023 200,000,000 0 0% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q4 2022 200,000,000 0 0% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 200,000,000 0 0% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q4 2020 200,000,000 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q2 2018 200,000,000 31 May 2018 10-K 25 Feb 2021 2020 FY
Q1 2018 44,746,463 28 Feb 2018 10-K 25 Feb 2021 2020 FY
Q4 2017 43,918,239 31 Dec 2017 10-K 25 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.